Jacob Safier

Advisor at BelHealth Investment Partners LLC

Jacob Safier

Jacob Safier

Advisor at BelHealth Investment Partners LLC

Biography

Jacob Safier

Advisory Member

Jacob Safier serves on Advisory Board.

Mr. Safier is a managing member of the Wolfson Group, an institution that owns and manages a large portfolio of commercial real estate and actively invests in a diverse array of investments and investment vehicles, including a substantial portfolio of hedge funds and private equity funds. Mr. Safier is also a private investor and entrepreneur.

Overview
RelSci Relationships

51

Number of Boards

1

Relationships
RelSci Relationships are individuals Jacob Safier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Sandata Technologies LLC

Relationship likelihood: Strong

Co-Founder at BelHealth Investment Partners LLC

Relationship likelihood: Strong

Co-Founder at BelHealth Investment Partners LLC

Relationship likelihood: Strong

Chief Financial Officer & CAO at BelHealth Investment Partners LLC

Relationship likelihood: Strong

Manager at Freedom Health, Inc.

Relationship likelihood: Strong

Founding Partner at Mansfield Bronstein, PA

Relationship likelihood: Strong

Founder at Laffer Investments, Inc.

Relationship likelihood: Strong

Former Governor of Pennsylvania

Relationship likelihood: Strong

General Counsel at BelHealth Investment Partners LLC

Relationship likelihood: Strong

Controller at BelHealth Investment Partners LLC

Relationship likelihood: Strong

Paths to Jacob Safier
Potential Connections via
Relationship Science
You
Jacob Safier
Advisor at BelHealth Investment Partners LLC
Career History
Managing Member
Current
Advisor
Current

BelHealth Investment Partners focuses exclusively on investments in small-cap companies in the healthcare industry. The firm targets undervalued or undermanaged, founder-owned, public or private companies in which their operating experience and resources can drive growth and profitability. BelHealth invests primarily in low to medium technology companies in the healthcare services, healthcare information technology, marketed pharmaceutical and marketed medical products industries.BelHealth looks for companies with enterprise value up to $100 million, revenues of $10 million to $100 million, proforma operating profits near break-even up to $10 million and the potential to improve operating margins. In addition, they seek companies with long-term competitive advantages in attractive potential markets and the potential for profitable exit opportunities within 3 to 5 years. BelHealth targets early growth stage companies with recurring revenue models, low customer concentration, little or no exposure to reimbursement risk, the potential for margin expansion and low operating leverage. The firm does not consider investments in companies that have not yet generated revenue, depend heavily on government reimbursement, market commodity products/services or companies requiring significant capital investment.BelHealth typically invests $10 million to $20 million per company. Investments are generally structured as equity stakes, although BelHealth may also use other structures such as convertible debt to mitigate or minimize risks as appropriate. They may utilize securities with liquidation preferences such as preferred, participating or convertible preferred stock or equity-linked debt. BelHealth employs a limited use of leverage. The firm prefers to make control investments, either through majority ownership and/or board control. BelHealth also prefers to participate in situations in which management retains meaningful ownership and receives compensation packages that reward strong performance.

Boards & Committees
Member, Advisory Board
Current

BelHealth invests in lower middle market companies located in the US. The firm focuses on companies with an enterprise value of $20 - $100 million, revenues between $10 and $100 million and EBITDA of $2 - $10 million. It targets companies operating in the fields of healthcare sectors, includes services, products and distribution.The firm acquires majority position and provides financing for buyout transactions with an investment size of $20 - $50 million. It takes seat on the board of directors.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jacob Safier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jacob Safier's profile does not indicate a business or promotional relationship of any kind between RelSci and Jacob Safier.